Medifast
MED
125 hedge funds and large institutions have $255M invested in Medifast in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 54 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 129 → 125 (-4)
5.95% less ownership
Funds ownership: 84.68% → 78.72% (-6%)
11% less call options, than puts
Call options by funds: $110K | Put options by funds: $124K
19% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 54
23% less capital invested
Capital invested by funds: $332M → $255M (-$76.3M)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.92M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.02M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.71M |
| 4 |
Millennium Management
New York
|
+$1.35M |
| 5 |
Renaissance Technologies
New York
|
+$1.27M |
Top Sellers
| 1 |
1WCM
12 West Capital Management
New York
|
-$9.92M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.1M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
-$3.51M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.96M |
| 5 |
CCPM
Cooper Creek Partners Management
New York
|
-$2.09M |
MED Hedge Fund Activity: Q3 2015 in Review
125 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2015, worth a combined $255M — down 23% from $332M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MED and 11 opened new positions — a net loss of 4 holders — while 54 trimmed existing stakes and 44 added.
The largest buyer was Morgan Stanley, adding an estimated $3.92M. The largest seller was 12 West Capital Management, exiting entirely with an estimated $9.92M sold.
- 125 institutional investors held Medifast (MED) as of Q3 2015, down from 129 in Q2 2015.
- Funds reported $255M of Medifast stock for Q3 2015, down 23% quarter-over-quarter.
- 11 funds opened new Medifast positions in Q3 2015 and 15 closed out, a net change of -4 holders.
- The largest Medifast buyer in Q3 2015 was Morgan Stanley, an estimated $3.92M added.
- The largest Medifast seller in Q3 2015 was 12 West Capital Management, an estimated $9.92M sold.
Based on aggregated 13F filings for Q3 2015.